10x Genomics Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 1,239
Employees
  • Stock Symbol
  • TXG
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $68.54
  • (As of Monday Closing)

10x Genomics General Information

Description

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Contact Information

Website
www.10xgenomics.com
Formerly Known As
Avante Biosystems Inc., 10x Technologies
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 6230 Stoneridge Mall Road
  • Pleasanton, CA 94588-3260
  • United States
+1 (925) 000-0000

10x Genomics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

10x Genomics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$68.54 $69.77 $66.40 - $208.99 $7.87B 113M 1.14M -$0.53

10x Genomics Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 16,119,702 16,119,702 14,529,946 6,935,213
Revenue 490,490 490,490 298,845 245,893
EBITDA (24,801) (24,801) (515,305) (23,693)
Net Income (58,223) (58,223) (542,731) (31,251)
Total Assets 1,018,826 1,018,826 929,341 605,923
Total Debt 81,978 81,978 62,978 29,719
Public Fundamental Data provided by Morningstar, Inc. disclaimer

10x Genomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore 10x Genomics‘s full profile, request access.

Request a free trial

10x Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore 10x Genomics‘s full profile, request access.

Request a free trial

10x Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, con
Biotechnology
Pleasanton, CA
1,239 As of 2021
00.000
00000000 00.000

00000000

rit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
0000000000000
San Francisco, CA
000 As of 0000
00000
000000000 00000

00000 00

agna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex e
0000000000000
Seattle, WA
00 As of 0000
000
0000000000 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

10x Genomics Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fluidigm Formerly VC-backed San Francisco, CA 000 00000 000000000 00000
00000 00000000 Venture Capital-Backed Seattle, WA 00 000 0000000000 000
000000 000000 0000 Formerly PE-Backed Waltham, MA 000000 000 00000000 000
0000 Corporation Wheeling, IL 00
00000000 Formerly VC-backed San Diego, CA 00000 00000 000000&0
You’re viewing 5 of 13 competitors. Get the full list »

10x Genomics Patents

  • 611

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 52

    Granted

  • 100

    Pending

  • 000

    Expiring in next 12 mo

10x Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-202020104928-U1 Tissue cutter Active 26-Aug-2020 000000000
US-20210327544-A1 Systems and methods for visualizing adaptive immune cell clonotyping data Pending 17-Apr-2020 000000000
US-20210324454-A1 Systems and methods for correcting sample preparation artifacts in droplet-based sequencing Pending 15-Apr-2020 0000000000
US-20210324465-A1 Systems and methods for analyzing and aggregating open chromatin signatures at single cell resolution Pending 15-Apr-2020 0000000000
US-20210332354-A1 Systems and methods for identifying differential accessibility of gene regulatory elements at single cell resolution Pending 15-Apr-2020 C12N15/1093
To view 10x Genomics’s complete patent history, request access »

10x Genomics Executive Team (23)

Name Title Board Seat Contact Info
Serge Saxonov Ph.D Chief Executive Officer & Founder
Justin McAnear Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Benjamin Hindson Co-Founder, Chief Scientific Officer, President & Board Member
Bradford Crutchfield Chief Commercial Officer
Jean Philibert Chief People Officer
You’re viewing 5 of 23 executive team members. Get the full list »

10x Genomics Board Members (10)

Name Representing Role Since
Bryan Roberts Ph.D Venrock Board Member 000 0000
John Stuelpnagel Self Chairman & Board Member 000 0000
Kimberly Popovits 10x Genomics Board Member 000 0000
Mathai Mammen Ph.D Self Board Member 000 0000
Paul Conley Ph.D 10x Genomics Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

10x Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

10x Genomics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore 10x Genomics‘s full profile, request access.

Request a free trial

10x Genomics Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 08-Jan-2021 0000000000 00.00 Biotechnology 00000000
00000000 13-Oct-2020 0000000000 00000 Discovery Tools (Healthcare) 00000 000
0000000 21-Aug-2020 0000000000 000.00 Drug Discovery 00000 000
0000000 00000 10-Dec-2018 0000000000 Biotechnology 00000 000
Epinomics 05-Mar-2018 Merger/Acquisition Biotechnology 00000 000
To view 10x Genomics’s complete acquisitions history, request access »

10x Genomics Subsidiaries (3)

Company Name Industry Location Founded
Tetramer Shop Biotechnology Kongens Lyngby, Denmark 2019
000000000 Biotechnology San Francisco, CA 0000
0000000 0000000000 Biotechnology Stockholm, Sweden 0000
To view 10x Genomics’s complete subsidiaries history, request access »